Use of Statins in Kidney Transplant Recipients in Norway

Kidney transplant recipients (KTRs) experience increased risk of cardiovascular disease. Guidelines recommend HMG-CoA reductase inhibitor (statin) therapy when tolerated. We aimed to study changes in the prescription of statins and patients’ adherence to treatment over time. A population-based obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Rønning, Marit, Hjellvik, Vidar, Sakshaug, Solveig, Blix, Hege Salvesen, Midtvedt, Karsten, Reisæter, Anna Varberg, Holdaas, Hallvard, Åsberg, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835204/
https://www.ncbi.nlm.nih.gov/pubmed/35162389
http://dx.doi.org/10.3390/ijerph19031370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835204/
https://www.ncbi.nlm.nih.gov/pubmed/35162389
http://dx.doi.org/10.3390/ijerph19031370

Ejemplares similares